AN2 Therapeutics

AN2 Therapeutics discovers and develops small-molecule therapeutics for hematologic diseases, infectious diseases, and oncology.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2022
Stage of Initial Investment
Series B
Initial Investment Year
2021
AN2 Portco Hover Image